Dash Bio - About the company
Dash Bio is a series B company based in Boston (United States), founded in 2024 by Ander Tallett and Dave Johnson. It operates as a Provider of automated bioanalysis platform for accelerated clinical drug development. Dash Bio has raised $47.5M in funding from Freestyle and The Aligned Fund. The company has 345 active competitors, including 15 funded and 86 that have exited. Its top competitors include companies like BioAgilytix, Solvias and Advion.
Company Details
Provider of automated bioanalysis platform for accelerated clinical drug development. It leverages AI and robotics to deliver high-quality assays with faster turnaround times for clinical trials and GLP studies. The company automates critical steps in bioanalysis, reducing costs and time to market. It focuses on clinical bioanalysis, specifically the testing of samples from clinical trial subjects. The platform integrates quality, automation, and regulatory compliance to enhance customer experience and outcomes.
- Website
- www.dash.bio/
- Email ID
- *****@dash.bio
- Phone Number
- +1 **********
Key Metrics
Founded Year
2024
Location
Boston, United States
Stage
Series B
Total Funding
$47.5M in 3 rounds
Latest Funding Round
Ranked
31st among 345 active competitors
Employee Count
40 as on Jun 30, 2026
Similar Companies
Sign up to download Dash Bio's company profile
Dash Bio's funding and investors
Dash Bio has raised a total funding of $47.5M over 3 rounds. Its first funding round was on Oct 02, 2024. Dash Bio has 6 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Dash Bio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 15, 2026 | 3966495 | Series B | 7224994 | 9947688 | 4845291 | 3592277 |
Jun 13, 2025 | 5392645 | Series A | 7211370 | 9329754 | 7107726 | |
Oct 02, 2024 | 7232634 | Seed | 4143501 | 4184841 |
Access funding benchmarks and valuations. Sign up today!View details of Dash Bio's funding rounds and investors
Dash Bio's founders and board of directors
Founder? Claim ProfileHere are the details of Dash Bio's key team members:
- Ander Tallett: Co-Founder & COO of Dash Bio.
- Dave Johnson: Co-founder & CEO of Dash Bio.
View details of Dash Bio's Founder profiles and Board Members
Dash Bio's employee count trend
Dash Bio has 40 employees as of Jun 26. Here is Dash Bio's employee count trend over the years:
Uncover Dash Bio's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Dash Bio's Competitors and alternates
Top competitors of Dash Bio include BioAgilytix, Solvias and Advion. Here is the list of Top 10 competitors of Dash Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | BioAgilytix 2008, Durham (United States), Acquired | Global bioanalytical services leader, supporting drug development across various modalities | - | 57/100 | |
2nd | Solvias 1999, Kaiseraugst (Switzerland), Acquired | Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals | - | 54/100 | |
3rd | Advion 1993, Ithaca (United States), Acquired | Mass spectrometry, chromatography, and purification solutions for scientific advancement | $45.6M | 50/100 | |
4th | ImmunXperts 2014, Charleroi (Belgium), Acquired | CRO specializing in human immune system based bioassay development services | $1M | 48/100 | |
5th | Nucro-Technics 1970, Scarborough (Canada), Acquired | Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services | - | - | 47/100 |
6th | Teena Biolabs 1999, Hyderabad (India), Acquired | Testing laboratory offering pharmacopeial tests, calibration & validation services | - | - | 46/100 |
7th | Evans Analytical Group 1978, San Diego (United States), Acquired | Materials testing and engineering sciences, accelerating innovation through multidisciplinary expertise | - | 46/100 | |
8th | Nordic Bioscience 1996, Herlev (Denmark), Late Stage | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | - | 46/100 | |
9th | Sitec Labs 2004, Mumbai (India), Unfunded | CRO offering bioequivalence and bioanalytical services | - | - | 45/100 |
10th |  Alderley Analytical 2013, Stockport (United Kingdom), Acquired | Provider of bioanalytical services for drug development programs and testing | $869K | 45/100 | |
31st | Dash Bio 2024, Boston (United States), Series B | Provider of automated bioanalysis platform for accelerated clinical drug development | $47.5M | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Dash Bio's competitors? Click here to see the top ones
Dash Bio's Investments and acquisitions
Dash Bio has made no investments or acquisitions yet.
Reports related to Dash Bio
Here is the latest report on Dash Bio's sector:
News related to Dash Bio
•
Dash Bio Secures $11M to Accelerate a New Era in BioanalysisPR Newswire•Jul 23, 2025•Dash Bio, The Aligned Fund
•
•
Dash Bio’s $6.5 Million Seed Financing RoundGlobal Legal Chronicle•Nov 01, 2024•Ropes & Gray, Dash Bio, Freestyle, Swift Ventures and 1 other
•
Dash Bio: Drug Development Company Secures $6.5 Million (Seed)Pulse 2.0•Oct 25, 2024•Life Extension Ventures, Swift Ventures, Freestyle, Dash Bio
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Dash Bio
Explore our recently published companies
- Credencesecuritysolutions - Unfunded company
- Auto-Ankauf-Muehlhausen - Germany based, Unfunded company
- Inocean Technology - Richmond based, 2008 founded, Unfunded company
- Velox Mart - Gandhinagar based, 2022 founded, Unfunded company
- Nielsenretail - United Kingdom based, Unfunded company
- AFIANT - Deadpooled company
